Activity of T-DM1 in Her2-positive breast cancer brain metastases - Bartsch, Rupert; Berghoff, Anna S.; Vogl, Ursula; Rudas, Margaretha; Bergen, Elisabeth; Dubsky, Peter; Dieckmann, Karin; Pinker, Katja; Bago-Horvath, Zsuzsanna; Galid, Arik; Oehler, Leopold; Zielinski, Christoph C.; et al. (Clinical & experimental metastasis, 2015)
Keywords: Adult; Antibodies, Monoclonal, Humanized - therapeutic use; Antineoplastic Agents - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biomedical and Life Sciences; Biomedicine; Brain Neoplasms - drug therapy; Brain Neoplasms - genetics; Brain Neoplasms - mortality; Brain Neoplasms - secondary; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - genetics; Breast Neoplasms - mortality; Breast Neoplasms - pathology; Cancer Research; Disease-Free Survival; Female; Hematology; Humans; Kaplan-Meier Estimate; Maytansine - analogs & derivatives; Maytansine - therapeutic use; Middle Aged; Oncology; Receptor, ErbB-2 - biosynthesis; Receptor, ErbB-2 - genetics; Research Paper; Retrospective Studies; Surgical Oncology; Trastuzumab; Systemic therapy; Breast cancer; Brain metastases; T-DM1; Her2 positive